Navigation Links
Zimmer Holdings, Inc. Reports Second Quarter 2009 Financial Results
Date:7/23/2009

WARSAW, Ind., July 23 /PRNewswire-FirstCall/ -- Zimmer Holdings, Inc. (NYSE and SWX: ZMH) today reported financial results for the quarter ended June 30, 2009. The Company reported second quarter net sales of $1.02 billion, a decrease of 5.5% reported and 0.6% constant currency from the second quarter of 2008. Diluted earnings per share for the quarter were $0.98 reported and $1.00 adjusted, a decrease of 2.9% adjusted from the prior year period.

"Our second quarter results provide further evidence that we are successfully stabilizing our business and making progress toward restoring positive momentum," said David Dvorak, Zimmer President and CEO. "We achieved sequential improvement in revenue on a day-rate basis for the quarter in six of our seven product categories, including Knees and Hips. We are once again reaffirming our 2009 sales and earnings guidance."

Net earnings for the second quarter were $210.1 million on a reported basis and $215.5 million on an adjusted basis, a decrease of 9.0% adjusted from the prior year period. Operating cash flow for the second quarter was $195.1 million. Net earnings for the first six months of 2009 were $412.3 million on a reported basis and $425.5 million on an adjusted basis, a decrease of 11.6% adjusted from the prior year period.

During the quarter, the Company utilized $36 million of cash to acquire 0.8 million shares under its $1.25 billion repurchase program. At the end of the quarter, $797 million of share repurchase authorization remained available under this program, which expires on December 31, 2009.

Guidance

The Company reaffirmed its full year 2009 sales and earnings guidance. Full year revenues for 2009 are expected to increase between 1% and 3% on a constant currency basis. Assuming foreign currency exchange rates remain consistent with current levels, the Company estimates that foreign currency translation will reduce revenue for 2009 by approximately 2.5%. Full year 2009 adjusted diluted earnings per share are projected to be in a range of $3.85 to $4.00.

Conference Call

The Company will conduct its second quarter 2009 investor conference call today, July 23, 2009, at 8:00 a.m. Eastern Time. The live audio webcast can be accessed via Zimmer's Investor Relations website at http://investor.zimmer.com. It will be archived for replay following the conference.

Individuals who wish to dial into the conference call may do so at (888) 881-6248. International callers should dial (706) 634-6422. A digital recording will be available two hours after the completion of the conference call from July 23, 2009 to August 6, 2009. To access the recording, U.S./Canada callers should dial (800) 642-1687, and International callers should dial (706) 645-9291, and enter the Conference ID, 16739971. A copy of this press release and other financial and statistical information about the periods to be presented in the conference call will be accessible through the Zimmer website at http://investor.zimmer.com.

Sales Tables

The following tables provide sales results by geographic segment and product category, as well as the percentage change compared to the prior year quarter and six months on both a reported and constant currency basis. Beginning in 2009, the Company's Dental product category sales are no longer included within its Reconstructive products category. Prior year amounts related to Dental product category sales have been reclassified to conform to the 2009 presentation.


      NET SALES - THREE MONTHS ENDED JUNE 30, 2009
                 (in millions, unaudited)


                                            Constant
                           Net  Reported    Currency
                          Sales  % Growth   % Growth
                          ----- ---------   --------
    Geographic Segments
         Americas          $590       (1)%        -%
         Europe             280      (14)        (1)
         Asia Pacific       150       (6)        (2)
                          -----
             Total        1,020       (6)        (1)
    Product Categories
      Reconstructive
         Americas           441       (2)        (2)
         Europe             225      (16)        (3)
         Asia Pacific       114       (5)        (1)
                          -----
             Total          780       (7)        (2)

        Knees
           Americas         272       (3)        (2)
           Europe           108      (14)         -
           Asia Pacific      58       (6)         -
                          -----
               Total        438       (6)        (1)

        Hips
           Americas         143       (4)        (3)
           Europe           112      (19)        (6)
           Asia Pacific      53       (4)        (2)
                          -----
               Total        308      (10)        (4)

        Extremities          34        8         13

      Dental                 53      (17)       (12)

      Trauma                 57        3          7

      Spine                  64       18         23

      OSP and other          66        1          3



        NET SALES - SIX MONTHS ENDED JUNE 30, 2009
                  (in millions, unaudited)


                                             Constant
                            Net  Reported    Currency
                           Sales  % Growth   % Growth
                           ----- ---------   --------
    Geographic Segments
         Americas         $1,184       (1)%       (1)%
         Europe              546      (14)         -
         Asia Pacific        283       (8)        (4)
                           -----
             Total         2,013       (6)        (1)
    Product Categories
      Reconstructive
         Americas            884       (2)        (1)
         Europe              444      (15)        (2)
         Asia Pacific        214       (7)        (3)
                           -----
             Total         1,542       (7)        (2)

        Knees
           Americas          548       (2)        (2)
           Europe            213      (13)         1
           Asia Pacific      106       (8)        (1)
                           -----
               Total         867       (6)        (1)

        Hips
           Americas          285       (4)        (3)
           Europe            219      (17)        (5)
           Asia Pacific      104       (5)        (5)
                           -----
               Total         608      (10)        (4)

        Extremities           67        6         10

      Dental                 100      (16)       (11)

      Trauma                 114        3          6

      Spine                  129       19         23

      OSP and other          128      (11)        (9)

About the Company

Founded in 1927 and headquartered in Warsaw, Indiana, Zimmer designs, develops, manufactures and markets orthopaedic reconstructive, spinal and trauma devices, dental implants, and related surgical products. Zimmer has operations in more than 25 countries around the world and sells products in more than 100 countries. Zimmer's 2008 sales were approximately $4.1 billion. The Company is supported by the efforts of more than 8,000 employees worldwide.

For more information about Zimmer, visit www.zimmer.com

Note on Non-GAAP Financial Measures

As used in this press release, the term "adjusted" refers to operating performance measures that exclude inventory step-up, acquisition, integration, realignment and other expenses and net curtailment and settlement gain. The term "constant currency" refers to any financial measure that excludes the effect of changes in foreign currency exchange rates. Reconciliations of these non-GAAP measures to the most directly comparable GAAP measure are included in this press release.

Zimmer Safe Harbor Statement

This press release contains forward-looking statements within the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 based on current expectations, estimates, forecasts and projections about the orthopaedics industry, management's beliefs and assumptions made by management. Forward-looking statements may be identified by the use of forward-looking terms such as "may," "will," "expects," "believes," "anticipates," "plans," "estimates," "projects," "assumes," "guides," "targets," "forecasts," and "seeks" or the negative of such terms or other variations on such terms or comparable terminology. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially. These risks and uncertainties include, but are not limited to, our compliance with the Corporate Integrity Agreement through 2012; the impact of our enhanced healthcare compliance global initiatives and business practices on our relationships with customers and consultants, our market share and our overall financial performance; the success of our quality initiatives; the outcome of the informal investigation by the U.S. Securities and Exchange Commission into Foreign Corrupt Practices Act matters announced in October 2007; price and product competition; changes in customer demand for our products and services caused by demographic changes or other factors; dependence on new product development, technological advances and innovation; shifts in the product category or regional sales mix of our products and services; supply and prices of raw materials and products; control of costs and expenses; our ability to obtain and maintain adequate intellectual property protection; our ability to successfully integrate acquired businesses; our ability to form and implement alliances; challenges relating to changes in and compliance with governmental laws and regulations affecting our U.S. and international businesses, including regulations of the U.S. Food and Drug Administration and foreign government regulators and tax obligations and risks; the impact of temporarily suspending U.S. distribution of one of our key hip replacement products; product liability and intellectual property litigation losses; reductions in reimbursement levels from third-party payors and cost-containment efforts of healthcare purchasing organizations; our ability to retain the independent agents and distributors who market our products; changes in general industry and market conditions, including domestic and international growth rates and general domestic and international economic conditions, including interest rate and currency exchange rate fluctuations; and the costs of defending or resolving putative class action securities litigation and lawsuits, investigations or other proceedings resulting from our September 2007 settlement with the U.S. government and other matters. For a further list and description of such risks and uncertainties, see our periodic reports filed with the U.S. Securities and Exchange Commission. We disclaim any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be set forth in our periodic reports. Readers of this document are cautioned not to place undue reliance on these forward-looking statements, since, while we believe the assumptions on which the forward-looking statements are based are reasonable, there can be no assurance that these forward-looking statements will prove to be accurate. This cautionary statement is applicable to all forward-looking statements contained in this document.

                              ZIMMER HOLDINGS, INC.
                       CONSOLIDATED STATEMENTS OF EARNINGS
                FOR THE THREE MONTHS ENDED JUNE 30, 2009 and 2008
                (in millions, except per share amounts, unaudited)

                                                                     % Inc/
                                                     2009      2008   (Dec)
                                                     ----      ----  ------
     Net Sales                                   $1,019.9  $1,079.5      (6)%
     Cost of products sold                          236.8     262.3     (11)
                                                    -----     -----
     Gross Profit                                   783.1     817.2      (4)
                                                    -----     -----

     Research and development                        49.9      48.3       3
     Selling, general and administrative            432.3     448.0      (4)
     Acquisition, integration, realignment and
      other                                          36.5      12.5     192
     Net curtailment and settlement                 (32.1)        -     100
                                                    -----      ----
          Operating expenses                        486.6     508.8      (5)
                                                    -----     -----

     Operating Profit                               296.5     308.4      (4)
     Interest and other, net                         (4.0)      6.8    (158)
                                                     ----       ---
     Earnings before income taxes                   292.5     315.2      (7)
     Provision for income taxes                      82.4      87.8      (6)
                                                     ----      ----
     Net Earnings                                   210.1     227.4      (7)

     Less: Net earnings attributable to
               noncontrolling interest                  -      (0.3)   (100)
                                                     ----      ----
     Net Earnings of Zimmer Holdings, Inc.         $210.1    $227.1      (7)
                                                   ======    ======

     Earnings Per Common Share
           Basic                                    $0.98     $0.99      (1)
           Diluted                                  $0.98     $0.99      (1)

     Weighted Average Common Shares Outstanding
         Basic                                      214.7     228.4
         Diluted                                    215.5     229.5


    Certain amounts in the 2008 consolidated statement of earnings have been
    reclassified to conform to the 2009 presentation.



                              ZIMMER HOLDINGS, INC.
                       CONSOLIDATED STATEMENTS OF EARNINGS
                 FOR THE SIX MONTHS ENDED JUNE 30, 2009 and 2008
                (in millions, except per share amounts, unaudited)

                                                                     % Inc/
                                                     2009      2008   (Dec)
                                                     ----      ----  ------
     Net Sales                                   $2,012.5  $2,138.7      (6)%
     Cost of products sold                          467.1     517.0     (11)
                                                    -----     -----
     Gross Profit                                 1,545.4   1,621.7      (5)
                                                  -------   -------

     Research and development                       101.7      96.1       6
     Selling, general and administrative            856.0     865.8      (1)
     Acquisition, integration, realignment and
      other                                          43.5      19.8     120
     Net curtailment and settlement                 (32.1)        -     100
                                                    -----      ----
          Operating expenses                        969.1     981.7      (1)
                                                    -----     -----

     Operating Profit                               576.3     640.0     (10)
     Interest and other, net                         (7.7)      7.8    (198)
                                                     ----       ---
     Earnings before income taxes                   568.6     647.8     (12)
     Provision for income taxes                     156.3     180.9     (14)
                                                    -----     -----
     Net Earnings                                   412.3     466.9     (12)

     Less: Net earnings attributable to
               noncontrolling interest                  -      (0.5)   (100)
                                                     ----      ----
     Net Earnings of Zimmer Holdings, Inc.         $412.3    $466.4     (12)
                                                   ======    ======

     Earnings Per Common Share
           Basic                                    $1.89     $2.02      (6)
           Diluted                                  $1.88     $2.01      (6)

     Weighted Average Common Shares Outstanding
         Basic                                      218.1     230.5
         Diluted                                    218.8     231.7


    Certain amounts in the 2008 consolidated statement of earnings have been
    reclassified to conform to the 2009 presentation.



                    ZIMMER HOLDINGS, INC.
            CONDENSED CONSOLIDATED BALANCE SHEETS
                  (in millions, unaudited)

                                   June 30,    December 31,
                                    2009           2008
                                    ----           ----

     Assets
     Current Assets:
       Cash and cash
        equivalents                $277.5         $212.6
       Restricted cash                2.7            2.7
       Receivables, net             768.7          732.8
       Inventories, net             980.9          928.3
       Other current assets         298.9          302.2
                                    -----          -----
           Total current
            assets                2,328.7        2,178.6

     Property, plant and
      equipment, net              1,254.4        1,264.1
     Goodwill                     2,814.6        2,774.8
     Intangible assets, net         874.6          872.1
     Other assets                   189.8          149.4
                                    -----          -----
     Total Assets                $7,462.1       $7,239.0
                                 ========       ========

     Liabilities and Shareholders'
      Equity

     Current liabilities           $669.2         $771.1
     Other long-term
      liabilities                   333.8          353.9
     Long-term debt                 653.5          460.1
     Shareholders' equity         5,805.6        5,653.9
                                  -------        -------
     Total Liabilities and
      Shareholders' Equity       $7,462.1       $7,239.0
                                 ========       ========



                             ZIMMER HOLDINGS, INC.
                     CONSOLIDATED STATEMENTS OF CASH FLOWS
                FOR THE SIX MONTHS ENDED JUNE 30, 2009 and 2008
                            (in millions, unaudited)

                                                              2009    2008
                                                              ----    ----

     Cash flows provided by (used in) operating
      activities
     Net earnings of Zimmer Holdings, Inc.                  $412.3  $466.4
     Depreciation and amortization                           161.4   129.2
     Gain on sale of investments                                 -    (8.7)
     Net curtailment and settlement                          (32.1)      -
     Share-based compensation                                 40.1    39.4
     Inventory step-up                                         7.0     1.8
     Income tax benefits from employee stock
      compensation plans                                       0.2    10.0
     Excess income tax benefits from employee stock
      compensation plans                                         -    (6.0)
     Changes in operating assets and liabilities
         Income taxes                                          4.8   (35.7)
         Receivables                                         (29.8)  (81.9)
         Inventories                                         (51.8)  (55.6)
         Accounts payable and accrued expenses              (119.4)   87.6
         Other assets and liabilities                        (13.0)  (23.2)
                                                             -----   -----
     Net cash provided by operating activities               379.7   523.3
                                                             -----   -----

     Cash flows provided by (used in) investing activities
     Additions to instruments                                (75.9) (119.5)
     Additions to other property, plant and equipment        (54.7) (121.5)
     Acquisition of intellectual property rights             (25.9)      -
     Proceeds from sale of investments                           -    12.0
     Investments in other assets                             (17.8)   (7.5)
                                                             -----    ----
     Net cash used in investing activities                  (174.3) (236.5)
                                                            ------  ------

     Cash flows provided by (used in) financing activities
     Net borrowings under credit facilities                  200.0   220.0
     Proceeds from employee stock compensation plans           3.6    45.2
      Excess income tax benefits from employee stock
       compensation plans                                        -     6.0
     Repurchase of common stock                             (337.8) (640.2)
     Acquisition of noncontrolling interest                   (7.8)      -
                                                              ----    ----
     Net cash used in financing activities                  (142.0) (369.0)
                                                            ------  ------

     Effect of exchange rates on cash and cash equivalents     1.5     6.4
                                                               ---     ---

     Increase in cash and cash equivalents                    64.9   (75.8)
     Cash and cash equivalents, beginning of period          212.6   463.9
                                                             -----   -----
     Cash and cash equivalents, end of period               $277.5  $388.1
                                                            ======  ======



                            ZIMMER HOLDINGS, INC.
                       NET SALES BY GEOGRAPHIC SEGMENT
          FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2009 and 2008
                           (in millions, unaudited)

                   Three Months Ended June 30,    Six Months Ended June 30,
                   --------------------------     ------------------------
                                        %                           %
                        2009     2008  (Dec)       2009     2008  (Dec)
                        ----     ----  -----       ----     ----  -----

     Americas         $589.6   $594.5     (1)% $1,184.2 $1,201.6     (1)%
     Europe            280.4    325.8    (14)     545.5    631.3    (14)
     Asia Pacific      149.9    159.2     (6)     282.8    305.8     (8)
                       -----    -----             -----    -----
     Total          $1,019.9 $1,079.5     (6)  $2,012.5 $2,138.7     (6)
                    ======== ========          ======== ========


                            ZIMMER HOLDINGS, INC.
                        NET SALES BY PRODUCT CATEGORY
          FOR THE THREE AND SIX MONTHS ENDED JUNE 30, 2009 and 2008
                           (in millions, unaudited)

                   Three Months Ended June 30,  Six Months Ended June 30,
                   --------------------------   ------------------------

                                      % Inc/                     % Inc/
                        2009     2008  (Dec)       2009     2008  (Dec)
                        ----     ---- ------       ----     ---- ------

     Reconstructive   $780.0   $841.1     (7)% $1,541.6 $1,656.6     (7)%
     Dental             52.7     63.3    (17)     100.1    119.1    (16)
     Trauma             56.7     54.9      3      113.6    110.6      3
     Spine              64.2     54.3     18      128.8    108.3     19
     OSP and other      66.3     65.9      1      128.4    144.1    (11)
                        ----     ----             -----    -----
     Total          $1,019.9 $1,079.5     (6)  $2,012.5 $2,138.7     (6)
                    ======== ========          ======== ========



                    ZIMMER HOLDINGS, INC.
            RECONCILIATION OF REPORTED % GROWTH TO
                  CONSTANT CURRENCY % GROWTH
                         (unaudited)


                              For the Three Months Ended
                                    June 30, 2009
                                    -------------
                                        Foreign   Constant
                            Reported   Exchange   Currency
                            % Growth    Impact    % Growth
                            --------    ------    --------
    Geographic Segments
         Americas               (1)%       (1)%        -%
         Europe                (14)       (13)        (1)
         Asia Pacific           (6)        (4)        (2)
             Total              (6)        (5)        (1)
    Product Categories
      Reconstructive
         Americas               (2)         -         (2)
         Europe                (16)       (13)        (3)
         Asia Pacific           (5)        (4)        (1)
             Total              (7)        (5)        (2)

        Knees
           Americas             (3)        (1)        (2)
           Europe              (14)       (14)         -
           Asia Pacific         (6)        (6)         -
               Total            (6)        (5)        (1)

        Hips
           Americas             (4)        (1)        (3)
           Europe              (19)       (13)        (6)
           Asia Pacific         (4)        (2)        (2)
               Total           (10)        (6)        (4)

        Extremities              8         (5)        13

      Dental                   (17)        (5)       (12)

      Trauma                     3         (4)         7

      Spine                     18         (5)        23

      OSP and other              1         (2)         3



                    ZIMMER HOLDINGS, INC.
            RECONCILIATION OF REPORTED % GROWTH TO
                  CONSTANT CURRENCY % GROWTH
                         (unaudited)


                             For the Six Months Ended
                                  June 30, 2009
                                  -------------
                                      Foreign  Constant
                          Reported   Exchange  Currency
                          % Growth    Impact   % Growth
                          --------    ------   --------
    Geographic Segments
         Americas               (1)%        -%       (1)%
         Europe                (14)       (14)        -
         Asia Pacific           (8)        (4)       (4)
             Total              (6)        (5)       (1)
    Product Categories
      Reconstructive
         Americas               (2)        (1)       (1)
         Europe                (15)       (13)       (2)
         Asia Pacific           (7)        (4)       (3)
             Total              (7)        (5)       (2)

        Knees
           Americas             (2)         -        (2)
           Europe              (13)       (14)        1
           Asia Pacific         (8)        (7)       (1)
               Total            (6)        (5)       (1)

        Hips
           Americas             (4)        (1)       (3)
           Europe              (17)       (12)       (5)
           Asia Pacific         (5)         -        (5)
               Total           (10)        (6)       (4)

        Extremities              6         (4)       10

      Dental                   (16)        (5)      (11)

      Trauma                     3         (3)        6

      Spine                     19         (4)       23

      OSP and other            (11)        (2)       (9)



                              ZIMMER HOLDINGS, INC.
            Reconciliation of Net Earnings and Adjusted Net Earnings
                For the Three Months Ended June 30, 2009 and 2008
                            (in millions, unaudited)

                                                              Three Months
                                                              Ended June 30,
                                                              -------------
                                                               2009    2008
                                                               ----    ----

     Net Earnings                                            $210.1  $227.1
     Inventory step-up                                          2.8     1.5
     Acquisition, integration, realignment and other           36.5    12.5
     Net curtailment and settlement                           (32.1)      -
     Taxes on inventory step-up, acquisition, integration,
      realignment and other and net curtailment and
      settlement                                               (1.8)   (4.2)
                                                               ----    ----
     Adjusted Net Earnings                                   $215.5  $236.9
                                                             ======  ======


                              ZIMMER HOLDINGS, INC.
            Reconciliation of Net Earnings and Adjusted Net Earnings
                 For the Six Months Ended June 30, 2009 and 2008
                            (in millions, unaudited)

                                                               Six Months
                                                              Ended June 30,
                                                              -------------
                                                               2009    2008
                                                               ----    ----

     Net Earnings                                            $412.3  $466.4
     Inventory step-up                                          7.0     1.8
     Acquisition, integration, realignment and other           43.5    19.8
     Net curtailment and settlement                           (32.1)      -
     Taxes on inventory step-up, acquisition, integration,
      realignment and other and net curtailment and
      settlement                                               (5.2)   (6.8)
                                                               ----    ----
     Adjusted Net Earnings                                   $425.5  $481.2
                                                             ======  ======



                            ZIMMER HOLDINGS, INC.
            Reconciliation of Diluted EPS and Adjusted Diluted EPS
              For the Three Months Ended June 30, 2009 and 2008
                                 (unaudited)

                                                             Three Months
                                                            Ended June 30,
                                                            -------------
                                                             2009   2008
                                                             ----   ----

     Diluted EPS                                            $0.98  $0.99
     Inventory step-up                                       0.01   0.01
     Acquisition, integration, realignment and other         0.17   0.05
     Net curtailment and settlement                         (0.15)     -
      Taxes on inventory step-up, acquisition, integration,
      realignment and other and net curtailment and
      settlement                                            (0.01) (0.02)
                                                            -----  -----
     Adjusted Diluted EPS                                   $1.00  $1.03
                                                            =====  =====


                            ZIMMER HOLDINGS, INC.
            Reconciliation of Diluted EPS and Adjusted Diluted EPS
               For the Six Months Ended June 30, 2009 and 2008
                                 (unaudited)

                                                             Six Months
                                                            Ended June 30,
                                                            -------------
                                                             2009   2008
                                                             ----   ----

     Diluted EPS                                            $1.88  $2.01
     Inventory step-up                                       0.03   0.01
     Acquisition, integration, realignment and other         0.20   0.09
     Net curtailment and settlement                         (0.15)     -
      Taxes on inventory step-up, acquisition, integration,
       realignment and other and net curtailment and
       settlement                                           (0.02) (0.03)
                                                            -----  -----
     Adjusted Diluted EPS                                   $1.94  $2.08
                                                            =====  =====



                            ZIMMER HOLDINGS, INC.
                Reconciliation of 2009 Projected Diluted EPS
                      and Projected Adjusted Diluted EPS
                                 (unaudited)


     Projected Twelve Months Ended December 31, 2009:        Low    High
                                                             ---    ----

     Diluted EPS                                            $3.68  $3.83
     Inventory step-up                                       0.05   0.05
     Acquisition, integration, realignment and other         0.35   0.35
     Net curtailment and settlement                         (0.15) (0.15)
     Taxes on inventory step-up, acquisition, integration,
      realignment and other and net curtailment and
      settlement                                            (0.08) (0.08)
                                                            -----  -----
     Adjusted Diluted EPS                                   $3.85  $4.00
                                                            =====  =====



'/>"/>
SOURCE Zimmer Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved


Related medicine news :

1. Zimmer Holdings Offer and ORTHOsoft Directors Circular Mailed to Shareholders
2. Zimmer Holdings Announces Live Audio Webcast and Conference Call of Third Quarter 2007 Results
3. Zimmer Announces Successful Completion of ORTHOsoft Takeover Bid
4. Zimmer Holdings to Present at Upcoming Investor Conferences
5. Ray Elliott to Retire as Chairman of Zimmer Holdings; John McGoldrick to Serve as Non-Executive Chairman
6. Zimmer Holdings Receives FDA Approval to Market Mobile Bearing Knee
7. Zimmer Holdings to Present at JPMorgan Healthcare Conference
8. Zimmer Holdings Announces Webcast and Conference Call of Fourth Quarter and Full-Year 2007 Results
9. Zimmer Spine Introduces New Rigid to Dynamic Stabilization Transition System
10. Zimmer Reports Fourth Quarter and 2007 Financial Results
11. Zimmer Holdings to Present at Merrill Lynch Health Care Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/6/2016)... ... February 06, 2016 , ... With the FCPX LUT: Summer ... to their footage. A LUT is a Lookup Table that contains a mathematical formula ... indicated by the table. By manipulating each pixel, LUT's can change each color range ...
(Date:2/5/2016)... ... February 05, 2016 , ... Love is in the air ... variety of colors, assortments and packaging. This staple for Valentine’s Day is a must-have, ... , For Valentine’s Day, not only are long-stem roses available, but also other ...
(Date:2/5/2016)... ... February 05, 2016 , ... The event is being held on ... Center in Minneapolis, Minn. Triumph Over Parkinson’s will fund nearly $100,000 for research for ... Furniture, lives with Parkinson’s disease and is the architect of this informative event to ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... H. Van Allen have signed a joint enrollment and degree completion agreement. ... toward associate and baccalaureate degrees at FHU|Dickson. , The agreement allows students ...
(Date:2/5/2016)... ... February 05, 2016 , ... ... from across the country gathered at the La Valencia Hotel in San Diego, ... PROSHRED Chicago was named the year’s most outstanding franchise, walking away with the ...
Breaking Medicine News(10 mins):
(Date:2/5/2016)... http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ) has ... Obstetrics Partnering 2010-2016: Deal trends, players and ... --> http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ) has announced ... Partnering 2010-2016: Deal trends, players and financials" ... --> Research and Markets ( http://www.researchandmarkets.com/research/hcdvg6/global_obstetrics ...
(Date:2/4/2016)... , Feb. 4, 2016  The Senior Care ... Government Reform Committee Chairman Jason Chaffetz ... holding today,s hearing , "Developments in the ... increases and growing questions about abusive pharmacy benefit ... (R-UT) and Ranking Member Elijah Cummings (D-MD) ...
(Date:2/4/2016)... 4, 2016  SciClone Pharmaceuticals, Inc. (NASDAQ: ... entered into a settlement agreement with the United ... the SEC,s investigation into possible violations of the ... of the settlement agreement, SciClone has agreed to ... pre-judgment interest and a penalty.  This payment is ...
Breaking Medicine Technology: